Report Detail

Request for Sample of this report

Pharma & Healthcare Global Anti-infectious Disease Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4505902
    • |
  • 04 February, 2023
    • |
  • Global
    • |
  • 103 Pages
    • |
  • GIR (Global Info Research)
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Anti-infectious Disease Drugs market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Anti-infectious Disease Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Anti-infectious Disease Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Anti-infectious Disease Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Anti-infectious Disease Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Anti-infectious Disease Drugs market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Aridis Pharmaceuticals, AiCuris, Sandoz, Anhui Jingfang Medical Industry Co.,Ltd and Beijing Double-Crane Pharmaceutical Co., Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Anti-infectious Disease Drugs market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Antibacterial Drugs
Antifungal Drugs
Antiviral Drugs
Antiparasitic Drugs
Market segment by Application
Hospital
Institute of Medicine
Clinic
Others
Major players covered
Aridis Pharmaceuticals
AiCuris
Sandoz
Anhui Jingfang Medical Industry Co.,Ltd
Beijing Double-Crane Pharmaceutical Co., Ltd.
Abbott
Spero Therapeutics
Adlyfe, Inc.
Advanced Life Sciences Holdings, Inc.
Affinium Pharmaceuticals
APP Pharmaceuticals
Aquapharm Biodiscovery
Basilea Pharmaceutica AG
Biophage Pharma, Inc.
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti-infectious Disease Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Anti-infectious Disease Drugs, with price, sales, revenue and global market share of Anti-infectious Disease Drugs from 2018 to 2023.
Chapter 3, the Anti-infectious Disease Drugs competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti-infectious Disease Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Anti-infectious Disease Drugs market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Anti-infectious Disease Drugs.
Chapter 14 and 15, to describe Anti-infectious Disease Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Anti-infectious Disease Drugs
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Anti-infectious Disease Drugs Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Antibacterial Drugs
    • 1.3.3 Antifungal Drugs
    • 1.3.4 Antiviral Drugs
    • 1.3.5 Antiparasitic Drugs
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Anti-infectious Disease Drugs Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Hospital
    • 1.4.3 Institute of Medicine
    • 1.4.4 Clinic
    • 1.4.5 Others
  • 1.5 Global Anti-infectious Disease Drugs Market Size & Forecast
    • 1.5.1 Global Anti-infectious Disease Drugs Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Anti-infectious Disease Drugs Sales Quantity (2018-2029)
    • 1.5.3 Global Anti-infectious Disease Drugs Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Aridis Pharmaceuticals
    • 2.1.1 Aridis Pharmaceuticals Details
    • 2.1.2 Aridis Pharmaceuticals Major Business
    • 2.1.3 Aridis Pharmaceuticals Anti-infectious Disease Drugs Product and Services
    • 2.1.4 Aridis Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Aridis Pharmaceuticals Recent Developments/Updates
  • 2.2 AiCuris
    • 2.2.1 AiCuris Details
    • 2.2.2 AiCuris Major Business
    • 2.2.3 AiCuris Anti-infectious Disease Drugs Product and Services
    • 2.2.4 AiCuris Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 AiCuris Recent Developments/Updates
  • 2.3 Sandoz
    • 2.3.1 Sandoz Details
    • 2.3.2 Sandoz Major Business
    • 2.3.3 Sandoz Anti-infectious Disease Drugs Product and Services
    • 2.3.4 Sandoz Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Sandoz Recent Developments/Updates
  • 2.4 Anhui Jingfang Medical Industry Co.,Ltd
    • 2.4.1 Anhui Jingfang Medical Industry Co.,Ltd Details
    • 2.4.2 Anhui Jingfang Medical Industry Co.,Ltd Major Business
    • 2.4.3 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Product and Services
    • 2.4.4 Anhui Jingfang Medical Industry Co.,Ltd Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 Anhui Jingfang Medical Industry Co.,Ltd Recent Developments/Updates
  • 2.5 Beijing Double-Crane Pharmaceutical Co., Ltd.
    • 2.5.1 Beijing Double-Crane Pharmaceutical Co., Ltd. Details
    • 2.5.2 Beijing Double-Crane Pharmaceutical Co., Ltd. Major Business
    • 2.5.3 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Product and Services
    • 2.5.4 Beijing Double-Crane Pharmaceutical Co., Ltd. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Beijing Double-Crane Pharmaceutical Co., Ltd. Recent Developments/Updates
  • 2.6 Abbott
    • 2.6.1 Abbott Details
    • 2.6.2 Abbott Major Business
    • 2.6.3 Abbott Anti-infectious Disease Drugs Product and Services
    • 2.6.4 Abbott Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 Abbott Recent Developments/Updates
  • 2.7 Spero Therapeutics
    • 2.7.1 Spero Therapeutics Details
    • 2.7.2 Spero Therapeutics Major Business
    • 2.7.3 Spero Therapeutics Anti-infectious Disease Drugs Product and Services
    • 2.7.4 Spero Therapeutics Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 Spero Therapeutics Recent Developments/Updates
  • 2.8 Adlyfe, Inc.
    • 2.8.1 Adlyfe, Inc. Details
    • 2.8.2 Adlyfe, Inc. Major Business
    • 2.8.3 Adlyfe, Inc. Anti-infectious Disease Drugs Product and Services
    • 2.8.4 Adlyfe, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Adlyfe, Inc. Recent Developments/Updates
  • 2.9 Advanced Life Sciences Holdings, Inc.
    • 2.9.1 Advanced Life Sciences Holdings, Inc. Details
    • 2.9.2 Advanced Life Sciences Holdings, Inc. Major Business
    • 2.9.3 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Product and Services
    • 2.9.4 Advanced Life Sciences Holdings, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Advanced Life Sciences Holdings, Inc. Recent Developments/Updates
  • 2.10 Affinium Pharmaceuticals
    • 2.10.1 Affinium Pharmaceuticals Details
    • 2.10.2 Affinium Pharmaceuticals Major Business
    • 2.10.3 Affinium Pharmaceuticals Anti-infectious Disease Drugs Product and Services
    • 2.10.4 Affinium Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Affinium Pharmaceuticals Recent Developments/Updates
  • 2.11 APP Pharmaceuticals
    • 2.11.1 APP Pharmaceuticals Details
    • 2.11.2 APP Pharmaceuticals Major Business
    • 2.11.3 APP Pharmaceuticals Anti-infectious Disease Drugs Product and Services
    • 2.11.4 APP Pharmaceuticals Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 APP Pharmaceuticals Recent Developments/Updates
  • 2.12 Aquapharm Biodiscovery
    • 2.12.1 Aquapharm Biodiscovery Details
    • 2.12.2 Aquapharm Biodiscovery Major Business
    • 2.12.3 Aquapharm Biodiscovery Anti-infectious Disease Drugs Product and Services
    • 2.12.4 Aquapharm Biodiscovery Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Aquapharm Biodiscovery Recent Developments/Updates
  • 2.13 Basilea Pharmaceutica AG
    • 2.13.1 Basilea Pharmaceutica AG Details
    • 2.13.2 Basilea Pharmaceutica AG Major Business
    • 2.13.3 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Product and Services
    • 2.13.4 Basilea Pharmaceutica AG Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Basilea Pharmaceutica AG Recent Developments/Updates
  • 2.14 Biophage Pharma, Inc.
    • 2.14.1 Biophage Pharma, Inc. Details
    • 2.14.2 Biophage Pharma, Inc. Major Business
    • 2.14.3 Biophage Pharma, Inc. Anti-infectious Disease Drugs Product and Services
    • 2.14.4 Biophage Pharma, Inc. Anti-infectious Disease Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 Biophage Pharma, Inc. Recent Developments/Updates

3 Competitive Environment: Anti-infectious Disease Drugs by Manufacturer

  • 3.1 Global Anti-infectious Disease Drugs Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Anti-infectious Disease Drugs Revenue by Manufacturer (2018-2023)
  • 3.3 Global Anti-infectious Disease Drugs Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Anti-infectious Disease Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Anti-infectious Disease Drugs Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Anti-infectious Disease Drugs Manufacturer Market Share in 2022
  • 3.5 Anti-infectious Disease Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Anti-infectious Disease Drugs Market: Region Footprint
    • 3.5.2 Anti-infectious Disease Drugs Market: Company Product Type Footprint
    • 3.5.3 Anti-infectious Disease Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Anti-infectious Disease Drugs Market Size by Region
    • 4.1.1 Global Anti-infectious Disease Drugs Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Anti-infectious Disease Drugs Consumption Value by Region (2018-2029)
    • 4.1.3 Global Anti-infectious Disease Drugs Average Price by Region (2018-2029)
  • 4.2 North America Anti-infectious Disease Drugs Consumption Value (2018-2029)
  • 4.3 Europe Anti-infectious Disease Drugs Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Anti-infectious Disease Drugs Consumption Value (2018-2029)
  • 4.5 South America Anti-infectious Disease Drugs Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Anti-infectious Disease Drugs Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 5.2 Global Anti-infectious Disease Drugs Consumption Value by Type (2018-2029)
  • 5.3 Global Anti-infectious Disease Drugs Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 6.2 Global Anti-infectious Disease Drugs Consumption Value by Application (2018-2029)
  • 6.3 Global Anti-infectious Disease Drugs Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 7.2 North America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 7.3 North America Anti-infectious Disease Drugs Market Size by Country
    • 7.3.1 North America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 8.2 Europe Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 8.3 Europe Anti-infectious Disease Drugs Market Size by Country
    • 8.3.1 Europe Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Anti-infectious Disease Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Anti-infectious Disease Drugs Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Anti-infectious Disease Drugs Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 10.2 South America Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 10.3 South America Anti-infectious Disease Drugs Market Size by Country
    • 10.3.1 South America Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Anti-infectious Disease Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Anti-infectious Disease Drugs Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Anti-infectious Disease Drugs Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Anti-infectious Disease Drugs Market Drivers
  • 12.2 Anti-infectious Disease Drugs Market Restraints
  • 12.3 Anti-infectious Disease Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Anti-infectious Disease Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Anti-infectious Disease Drugs
  • 13.3 Anti-infectious Disease Drugs Production Process
  • 13.4 Anti-infectious Disease Drugs Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Anti-infectious Disease Drugs Typical Distributors
  • 14.3 Anti-infectious Disease Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Anti-infectious Disease Drugs. Industry analysis & Market Report on Anti-infectious Disease Drugs is a syndicated market report, published as Global Anti-infectious Disease Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Anti-infectious Disease Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,208.56
    		4,812.84
    		6,417.12
    		531,604.80
    		797,407.20
    		1,063,209.60
    		292,702.80
    		439,054.20
    		585,405.60
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo